Evaluation of the Impact of Virtual Reality on Sedation Use in Patients Undergoing Regional Anesthesia for Scheduled Orthopedic Surgery

NCT ID: NCT07013695

Last Updated: 2025-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-18

Study Completion Date

2025-07-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The VIRTUALR study evaluates the effect of virtual reality combined with hypnosis on anxiety in patients undergoing orthopedic surgery under regional anesthesia. Patients are randomly assigned to two groups: one group receiving virtual reality and a control group without the device. Anxiety and satisfaction questionnaires are used to compare the two groups.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Orthopedic Procedure Anesthesia Sedation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized parallel-group study with two arms (virtual reality group vs. control group) comparing the effect of virtual reality on sedation use during regional anesthesia.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

virtual reality group

Participants in this group receive a virtual reality session with a hypnotic objective during surgery performed under regional anesthesia. The device consists of a virtual reality headset offering immersive visual and auditory content in a calming environment chosen by the participant. The session begins before the administration of regional anesthesia and may continue throughout the surgical procedure.

Group Type ACTIVE_COMPARATOR

Virtual reality headset

Intervention Type DEVICE

Patients in the intervention group receive a virtual reality session with a hypnotic purpose during surgery under regional anesthesia. The device consists of a virtual reality headset providing visual and auditory immersion in a calming environment, freely chosen by the patient. The session begins before the regional anesthesia is administered and may continue throughout the entire surgical procedure

Control Group

Participants in this group receive standard anesthetic and surgical care without the use of virtual reality.

Group Type PLACEBO_COMPARATOR

Standard Care (in control arm)

Intervention Type OTHER

Participants in this group receive standard anesthetic and surgical care without the use of virtual reality

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality headset

Patients in the intervention group receive a virtual reality session with a hypnotic purpose during surgery under regional anesthesia. The device consists of a virtual reality headset providing visual and auditory immersion in a calming environment, freely chosen by the patient. The session begins before the regional anesthesia is administered and may continue throughout the entire surgical procedure

Intervention Type DEVICE

Standard Care (in control arm)

Participants in this group receive standard anesthetic and surgical care without the use of virtual reality

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Patient affiliated with or benefiting from a social security system
* Patient aged 18 years or older
* Patient requiring regional anesthesia for scheduled orthopedic surgery of the upper or lower limb

Exclusion Criteria

* Patient refusal to participate in the study
* Device interfering with the surgical or anesthetic procedure
* Premedication before arrival in the operating room
* Psychiatric or cognitive disorders, communication disorders
* Patient unable to understand the study (language barrier, psychological issues)
* Emergency surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Eure-Seine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Baptiste HARDY

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Eure-Seine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Eure-Seine

Évreux, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lydia BEN BEKKOU

Role: CONTACT

02 32 33 86 75

Dihia AIDENE

Role: CONTACT

02 32 33 86 75

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

BEN BEKKOU Lydia

Role: primary

02 32 33 86 75

AIDENE Dihia

Role: backup

02 32 33 86 75

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A00055-38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.